Citizen Petition from The Doctor Patient Forum

A healthcare educator with three decades of experience argues for the immediate regulation and eventual abolishment of NarxCare. The commenter contends that the tool lacks clinical nuance, is not independently validated, and unfairly discriminates against patients by replacing individualized care with biased algorithms.

The commenter, a private individual suffering from chronic anxiety, opposes the use of artificial intelligence to determine eligibility for pain and anxiety medications. They argue that AI lacks the human capacity to understand personal suffering and cannot accurately assess a patient's needs.

A chronic pain patient is urging regulators to scrutinize and restrict the use of proprietary opioid-risk scoring tools like NarxCare. The commenter argues that these "black-box" algorithms lack transparency, can lead to patient harm by overriding individualized clinical judgment, and should be subject to independent validation and regulatory oversight.

A former health professional expresses opposition to the use of AI to review medical records and the use of Narxcare scores. The commenter argues that the current electronic health record system is flawed and that AI lacks the intelligence to handle medical data accurately, potentially hindering patient access to necessary medications.

The commenter argues that NarxCare is a dangerous, non-science-based tool that fails to account for individual patient differences. They suggest that the focus should be on preventing illegal drug entry and education rather than addressing prescription medications.

A psychiatry resident argues that automated risk stratification tools for controlled substances currently lack sufficient oversight and evidence of efficacy. They support the petition's call for a formal FDA review process to ensure these tools meet safety and quality standards before continued clinical use.

A patient with complex medical conditions and chronic pain is requesting that the FDA regulate NarxCare as Software as a Medical Device. The commenter argues that these AI tools need oversight to ensure they account for individual comorbidities and situational conditions when determining treatment eligibility.

The Doctor Patient Forum is advocating for the FDA to regulate NarxCare as Software as a Medical Device (SaMD). They argue that the current lack of regulation allows for biased algorithms that negatively impact patient care, lead to wrongful law enforcement actions, and lack necessary transparency and accountability.